← Leaderboards
Timothy R Peterson
Harvard University
$3,494,746
Attributed
$4,465,171
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2014–22$2M$1.5M$1M$500K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$4,465,171 · 5
By mechanism
R42$1,716,395 · 1
R01$1,568,717 · 1
R00$724,980 · 1
K99$230,624 · 1
R41$224,455 · 1
Top collaborators
- Brian N Finck4 shared
- Luke Gilbert1 shared
Most similar at Harvard University
Same institution · by research overlap
- John S Chant$555,574
- Craig A Leach$737,599
- Dario Cabrera$60,704
Others in their field
Top investigators on “Molecular”
- David Heimbrook · Leidos Biomedical Research, Inc.$871,088,761
- Leonard Freedman · Leidos Biomedical Research, Inc.$468,573,385
- Richard Webby · St. Jude Children'S Research Hospital$254,843,170
- Larry Arthur$238,531,074
- Gregory H Reaman · National Childhood Cancer Foundation$230,630,913
- Ralph Parchment · Leidos Biomedical Research, Inc.$193,231,914
Research focus
MolecularBasePharmaceutical PreparationsPhenotypeTissuesMediatingDiabetes MellitusCrispr InterferenceGenesCellsGenetic ScreeningGeneticBisphosphonateGene TargetingMouse ModelIn VitroDietPathway InteractionsClinical TrialsBiochemicalDoseDrug UsageBoneLink
Grant awards (14)
Novel insulin-sensitizing NASH/diabetes drugs.$497,526
R42 · FY2022 · DK · contact PI
Novel insulin-sensitizing NASH/diabetes drugs.$497,526
R42 · FY2021 · DK · contact PI
Genetic Factors of Bone Loss in Older Adults Taking Antidepressants$381,270
R01 · FY2021 · AR · contact PI
Novel insulin-sensitizing NASH/diabetes drugs.$497,526
R42 · FY2020 · DK · contact PI
Genetic Factors of Bone Loss in Older Adults Taking Antidepressants$393,061
R01 · FY2020 · AR · contact PI
Drug target identification using CRISPRi/a screening$224,455
R41 · FY2020 · GM · contact PI
Genetic Factors of Bone Loss in Older Adults Taking Antidepressants$391,939
R01 · FY2019 · AR · contact PI
Novel insulin-sensitizing NASH/diabetes drugs.$223,817
R42 · FY2019 · DK · contact PI
Genetic Factors of Bone Loss in Older Adults Taking Antidepressants$402,447
R01 · FY2018 · AR · contact PI
TBONE and phosphonates in mineralization during aging$230,670
R00 · FY2018 · AG · contact PI
TBONE and phosphonates in mineralization during aging$245,310
R00 · FY2017 · AG · contact PI
TBONE and phosphonates in mineralization during aging$249,000
R00 · FY2016 · AG · contact PI
TBONE and phosphonates in mineralization during aging$115,312
K99 · FY2015 · AG · contact PI
TBONE and phosphonates in mineralization during aging$115,312
K99 · FY2014 · AG · contact PI